**Core tip:** We acquired high-throughput data from The Cancer Genome Atlas database and constructed the competing endogenous RNA (ceRNA) networks of colorectal cancer by bioinformatics analysis, which included 81 differentially expressed (DE)lncRNAs, 20 DEmiRNAs, and 54 DEmRNAs. Furthermore, 3 lncRNAs, 3 miRNAs, and 2 mRNAs were found associated with overall survival. Our study revealed that ceRNA networks are important in colorectal cancer and the prognosis-related genes worth exploring further.

INTRODUCTION
============

Colorectal cancer (CRC) is one of the most common digestive malignancies in the world\[[@B1]\]. With the development of new technology in CRC diagnosis and treatment, the prognosis of patients with early detection has been improved. However, the overall 5-year survival rate in advanced cases remains poor\[[@B2]\]. In the United States, CRC was the fourth most common malignant tumor, with 135430 new cases and 50260 deaths in 2017\[[@B3]\]. Therefore, specific CRC biomarkers and therapeutic pathways are in great need to improve the prognosis for patients.

Non-coding RNAs, including microRNAs (miRNAs) and long-noncoding RNAs (lncRNAs), can regulate oncogene and tumor suppressor gene expression in multiple ways\[[@B4],[@B5]\]. MiRNAs are 20-22 nucleotides long and regulate genes post-transcriptionally by directly binding mRNAs\[[@B6]\]. LncRNAs are defined as transcripts that range from 200 nucleotides to multiple kilobases in length\[[@B7]\]. Recent research has focused on these lncRNAs, which function as competing endogenous RNAs (ceRNAs) to regulate gene expression by sponging miRNAs through shared miRNA response elements\[[@B8]\].

In the last few years, with the development of gene-sequencing technology, dysregulation of lncRNAs has been revealed in diverse malignancies. Studies have utilized bioinformatics tools to predict the target genes of novel lncRNAs, and molecular biology techniques including real time quantitative polymerase chain reaction (RT-qPCR), silencing technique, and luciferase reporter gene assays, among others, to validate *in silico* predictions. In CRC, the lncRNA UICLM acts as a ceRNA for hsa-miR-215 to upregulate ZEB2 expression and promote CRC progression\[[@B9]\]. Additionally, the lncRNA HNF1A-AS1 functions as an oncogene in the metastasis of CRC by modulating the hsa-miR-34/p53 axis\[[@B10]\]. Finally, the lncRNA CASC2 plays a role as a tumor suppressor gene by sponging hsa-miR-18a\[[@B11]\].

The lncRNA/miRNA/mRNA axis is regarded as an important mechanism in tumor progression and metastasis\[[@B12]\]. However, studies of ceRNA networks of novel coding and noncoding RNAs in CRC in large cohorts have not been performed. In our study, we obtained malignant and normal tissue expression profiles from The Cancer Genome Atlas (TCGA, <http://cancergenome.nih.gov>) project\[[@B13]\]. CeRNA networks were constructed including differentially expressed mRNAs (DEmRNAs), differentially expressed lncRNAs (DElncRNAs), and differentially expressed miRNAs (DEmiRNAs), which were based on the miRcode (<http://www.mircode.org/>)\[[@B14]\], miRTarBas (<http://mirtarbase.mbc.nctu.edu.tw/php/>)\[[@B15]\], TargetScan (<http://www.targetscan.org/>), and miRDB (<http://www.mirdb.org/>) databases\[[@B16]\]. Kaplan-Meier survival curve analysis was performed to identify differentially expressed genes (DEGs) that are associated with overall survival.

MATERIALS AND METHODS
=====================

Sample collection
-----------------

We downloaded CRC transcriptome profiles from TCGA through the Genomic Data Commons (GDC) Data Transfer Tool 1.3.0\[[@B13]\]. The public data included the tissue expression profiles (derived by RNA-seq) of 644 CRC tissues and 51 normal tissues (level 3) and 619 CRC and 11 normal tissue expression profiles (level 3) derived by miRNA-seq. According to the publication guidelines (2015) provided by TCGA (https://cancergenome.nih.gov/publications/publicationguidelines), our study does not require the approval of an ethics committee.

Identification of DEGs
----------------------

We analyzed the RNA-seq data by merging it to an RNA matrix with PERL software. Then, we converted the gene ID to gene name according to Ensembl (Homo sapiens) (<http://asia.ensembl.org/index.html>). The miRNA-seq data were analyzed using the same method. DEmRNAs, DElncRNAs, and DEmiRNAs were identified with the edgeR package in R with a threshold log~2~ fold change (FC) \> 2.0 and *P* \< 0.01. Heat maps of DEGs were constructed using the gplots package in R.

Functional analysis and ceRNA network construction
--------------------------------------------------

Next, we constructed ceRNA networks that were mapped by identifying DEGs to an established co-expression database (miRcode, miRTarBase, TargetScan, and miRDB). LncRNA-miRNA-mRNA reactions were split into lncRNA-miRNA and miRNA-mRNA interactions. LncRNA-miRNA interactions were predicted by comparing DElncRNAs and DEmiRNAs to the miRcode database. DEmRNAs regulating genes of DEmiRNAs were identified by intersecting the predicted results between miRTarBase, TargetScan, and the miRDB databases. According to the ceRNA hypothesis\[[@B12]\], miRNAs negatively regulate mRNA expression and lncRNAs act as ceRNAs to limit miRNA function by sponging them. The networks were visualized and mapped using Cytoscape v3.5.1\[[@B17]\].

To explore the function of the DEGs in the ceRNA networks in tumorigenesis and metastasis, KEGG pathways\[[@B18]\] were analyzed using KOBAS (<http://kobas.cbi.pku.edu.cn/>), which is a web server that annotates an input set of genes with pathways based on human disease databases\[[@B19]\]. Then, we utilized STRING protein database v10.5 (<http://string-db.org/>) to analyze the protein-protein interactions of the DEGs.

Association analysis between DEGs and CRC patient survival
----------------------------------------------------------

We selected CRC adenocarcinoma and adjacent normal tissue expression data and clinical information from TCGA project. None of the patients received preoperative treatment. Kaplan-Meier survival analysis and the log-rank test were performed for DEGs in the ceRNA networks. *P* \< 0.05 was regarded as statistically significant.

Cell lines and cell culture
---------------------------

The CRC cell lines HT29, LoVo, and SW480, along with the normal intestinal epithelial cell line NCM460, were purchased from the Institute of Biochemistry and Cell Biology at the Chinese Academy of Sciences, Shanghai, China. The cell lines were cultured in RPMI 1640 medium (HyClone, Logan, UT, United States) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, United States), 100 U/mL penicillin, and 100 μg/mL streptomycin. All cells were maintained in an incubator with a humidified atmosphere of 95% air and 5% CO~2~ at 37 °C.

DElncRNA detection
------------------

Total RNA was isolated from the cells using Trizol reagent (Invitrogen, Carlsbad, CA, United States). The quality and concentration of isolated RNA were detected with a NanoDrop 2000 spectrophotometer. Total RNA (800 ng) was converted to cDNA by using the PrimeScript TM RT reagent Kit (Takara, Otsu, Shiga, Japan). The Kit contained gDNA Eraser which could remove genomic DNA. We utilized LightCycler96 (Roche Diagnostic, Basel, Switzerland) to perform RT-qPCR using SYBR Green (Takara). The two-step amplification reaction was as follows: 95 °C for 30 s for preincubation, then 45 cycles of 95 °C for 10 s and 60 °C for 30 s. GAPDH expression was used as an endogenous control. Quantitative analysis was calculated using the 2^-ΔΔCt^ method\[[@B20]\]. Primers were designed as follows: POU6F2-AS2 forward, 5'-ACAGCAGTGCCAGAAGGAGTATTG-3' and reverse, 5'-GCAGACCTGAGCTTGTGAGTGAC-3'; LINC00488 forward, 5'-GAGCAGCAAGAATGAGAGCAGAGG-3' and reverse, 5'-GAATCTGAGGAAGCACCGTGAACC-3'; IGF2-AS forward, 5'-TCCACACCAGACAGCACAGACC-3' and reverse, 5'-TCCGTGGTTGGCTCCAGGTG-3'; GAPDH forward, 5'-AGCCACATCGCTCAGACAC-3' and reverse, 5'-GCCCAATACGACCAAATCC-3'.

Statistical analysis
--------------------

All data were analyzed using SPSS 20.0 (Chicago, IL, United States). Student's *t*-test was performed for CRC cell lines and normal intestinal epithelial cell line comparisons. Differences with *P* \< 0.05 were regarded as statistically significant. All experiments were repeated three times.

RESULTS
=======

Identification of DEGs in CRC
-----------------------------

We identified DElncRNAs and DEmRNAs between 644 CRC and 51 normal tissue expression profiles from TCGA. As a result, we identified 1043 DElncRNAs, 2146 DEmRNAs, and 276 DEmiRNAs using the edgeR package in R. There were 768 up-regulated and 275 down-regulated DEGs among the DElncRNAs, and 1198 up-regulated and 948 down-regulated DEGs in the DEmRNAs. Using the same method, 180 up-regulated and 96 down-regulated DEmiRNAs were obtained by comparing 619 CRC and 11 normal tissue expression profiles. Moreover, we constructed heat maps of the top DEGs (log~2~ FC \> 5, *P* \< 0.01) in each category using R (Figures [1](#F1){ref-type="fig"}-[](#F2){ref-type="fig"}[3](#F3){ref-type="fig"}).

![Heat map of differentially expressed long-noncoding RNAs (log~2~ FC \> 5, *P* \< 0.01). The above horizontal axis shows clusters of samples. The left vertical axis shows clusters of differentially expressed long-noncoding RNAs (DElncRNAs) and right vertical axis represents lncRNA names. Red represents up-regulated genes and green represents down-regulated genes. The yellow color column represents colorectal cancer; the blue represents normal.](WJG-24-5259-g001){#F1}

![Heat map of differentially expressed mRNAs (log~2~ FC \> 5, *P* \< 0.01). The above horizontal axis shows clusters of samples. The left vertical axis shows clusters of differentially expressed mRNAs and right vertical axis represents mRNA names. Red represents up-regulated genes and green represents down-regulated genes. The yellow color column represents colorectal cancer; the blue represents normal.](WJG-24-5259-g002){#F2}

![Heat map of differentially expressed microRNAs (log~2~ FC \> 5, P \< 0.01). The above horizontal axis shows clusters of samples. The left vertical axis shows clusters of differentially expressed microRNAs (DEmiRNAs) and right vertical axis represents miRNA names. Red represents up-regulated genes and green represents down-regulated genes. The yellow color column represents colorectal cancer; the blue represents normal.](WJG-24-5259-g003){#F3}

Construction of ceRNA networks
------------------------------

To construct the ceRNA networks, we predicted the interactions among DEGs using online bioinformatics tools. We utilized miRcode to predict the interactions between DElncRNAs and DEmiRNAs and we also predicted DEmRNAs targeted by the DEmiRNAs by intersecting the predictions of miRTarBase, TargetScan, and miRDB (Figure [4](#F4){ref-type="fig"}). Ultimately, 81 DElncRNAs, 20 DEmiRNAs, and 54 DEmRNAs were identified to construct the ceRNA networks of CRC using Cytoscape (Figure [5](#F5){ref-type="fig"}). The interactions among DEGs are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Putative differentially expressed long-noncoding RNAs that may target differentially expressed microRNAs

  **DEmiRNAs**   **DElncRNAs**                                                                                                                                                                                                                                                                                                         **DEmiRNAs**   **DElncRNAs**
  -------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- --------------------------------------------------------------------------------------------------------------------------------
  Hsa-miR-193b   IGF2-AS, H19, MIR31HG, WT1-AS, MUC19, UCA1, POU6F2-AS1, TSSC1-IT1, MRPL23-AS1, SPATA13-AS1, HOTAIR, WASIR2, DLX6-AS1, CRNDE, MALAT1, KCNQ1OT1                                                                                                                                                                         Hsa-miR-182    AC009336.1, C5orf64, AL360004.1, AC010336.2, SFTA1P, LINC00402, RBMS3-AS3, ADAMTS9-AS2, LIFR-AS1, FRMD6-AS2
  Hsa-miR-145    SHANK2-AS3, WT1-AS, MUC19, ST7-AS2, MRPL23-AS1, FAM155A-IT1, FAM41C, MIR205HG, DLX6-AS1, OSBPL10-AS1, ERVH48-1, CRNDE, PVT1, LINC00491, MALAT1, NKX2-1-AS1, KCNQ1OT1, AL139147.1, ITCH-IT1, LINC00452                                                                                                                 Hsa-miR-106a   C20orf166-AS1, AC010336.2, HCG23, JAZF1-AS1, LINC00484, ADAMTS9-AS2, ARHGEF26-AS1, LIFR-AS1, LINC00461, LINC00507
  Hsa-miR-187    SHANK2-AS3, MUC19, BTBD9-AS1, LINC00452, FAM41C, ATP11A-AS1, ERVH48-1, POU6F2-AS2, ARHGEF26-AS1, PVT1                                                                                                                                                                                                                 Hsa-miR-152    C5orf64, AL360004.1, FAM95B1, LINC00484, ADAMTS9-AS2
  Hsa-miR-150    IGF2-AS, C2orf48, SHANK2-AS3, C15orf54, HECW1-IT1, LINC00523, MUC19, ST7-OT4, CLDN10-AS1, TSSC1-IT1, MRPL23-AS1, BTBD9-AS1, LINC00355, LMO7-AS1, HOTAIR, MIR205HG, WASIR2, DLX6-AS1, LINC00460, LATS2-AS1, BOK-AS1, DSCAM-AS1, CAMTA1-IT1, PVT1, LINC00491, HULC, MALAT1, C8orf49, KCNQ1OT1, AL139147.1, AL391421.1   Hsa-miR-338    GRIK1-AS1, C5orf64, AC010336.2, LINC00473, FAM95B1, AC110491.1, LINC00402, LINC00484, ADAMTS9-AS2, LINC00461, FRMD6-AS2, PWRN1
  Hsa-miR-375    C15orf54, C17orf77, WT1-AS, MUC19, STEAP2-AS1, LMO7-AS1, HOTAIR, OSBPL10-AS1, POU6F2-AS2, MACROD2-AS1, DLEU7-AS1, MALAT1, C8orf49, KCNQ1OT1, AL139147.1                                                                                                                                                               Hsa-miR-17     C20orf166-AS1, C5orf64, AC010336.2, HCG23, JAZF1-AS1, LINC00402, ARHGEF26-AS1
  Hsa-miR-183    C20orf166-AS1, AL360004.1, FAM95B1, CHL1-AS2, ADAMTS9-AS2, LINC00507                                                                                                                                                                                                                                                  Hsa-miR-424    C5orf64, AL360004.1, LINC00473, LINC00092, SFTA1P, LINC00484, LINC00461, PWRN1
  Hsa-miR-98     LINC00488, FAM95B1, AC110491.1, JAZF1-AS1, LINC00484, ADAMTS9-AS2, PWRN1                                                                                                                                                                                                                                              Hsa-miR-21     C5orf64, AL360004.1, LINC00488, JAZF1-AS1, ADAMTS9-AS1, ARHGEF26-AS1, PWRN1
  Hsa-miR-144    AL360004.1, AC010336.2, LINC00488, ADAMTS9-AS1, ADAMTS9-AS2, LIFR-AS1, LINC00461, PWRN1                                                                                                                                                                                                                               Hsa-miR-454    C20orf166-AS1, ADAMTS9-AS1, ADAMTS9-AS2
  Hsa-miR-32     JAZF1-AS1, LINC00484, ADAMTS9-AS2, ARHGEF26-AS1                                                                                                                                                                                                                                                                       Hsa-miR-141    C5orf64, AC010336.2, FAM95B1, AC110491.1, LINC00402, LINC00484, ADAMTS9-AS2, ARHGEF26-AS1, LINC00461
  Hsa-miR-206    LINC00488, FAM95B1, LINC00092, SFTA1P, LINC00163, LINC00484, AL138995.1, LIFR-AS1, FRMD6-AS2                                                                                                                                                                                                                          Hsa-miR-372    C20orf166-AS1, AC010336.2, HCG23, JAZF1-AS1, LINC00484, ADAMTS9-AS2, ARHGEF26-AS1, LIFR-AS1, LINC00461

DElncRNAs: Differentially expressed long-noncoding RNAs; DEmiRNAs: Differentially expressed microRNAs.

###### 

Putative differentially expressed microRNAs that may target differentially expressed mRNAs

  **DEmiRNAs**   **DEmRNAs**
  -------------- -----------------------------------------------------------------
  Hsa-miR-193b   PLAU, PMAIP1, TCF7, CCND1, SHMT2
  Hsa-miR-145    SERPINE1, SOX2, MUC1, YES1
  Hsa-miR-187    LYN, RNPS1, MYLIP
  Hsa-miR-375    TRIM66, USP1, TGFB2, COL12A1, CBX3, SP1
  Hsa-miR-150    CBL, ZEB1, HILPDA, SLC7A11, DACH1, EREG, IGF2BP3, KIAA1549, MYB
  Hsa-miR-183    KIF5C
  Hsa-miR-98     HAND1
  Hsa-miR-144    CRIK3
  Hsa-miR-182    CHL1, FOXF2, TCEAL7, NPTX1
  Hsa-miR-152    NPTX1, BMP3, KLF4
  Hsa-miR-454    RBM20, CFL2
  Hsa-miR-106a   CFL2, FAM129A, CADM2
  Hsa-miR-372    TMEM100, CADM2,
  Hsa-miR-17     SLC16A9, CYBRD1, KLF4, CADM2, FAM129A
  Hsa-miR-424    TPM2, TMEM100
  Hsa-miR-21     ATP2B4, EDIL3, OSR1
  Hsa-miR-32     UGP2, PBLD, PHLPP2, ATP2B4
  Hsa-miR-141    ELAVL4, EPHA7, PHLPP2
  Hsa-miR-338    NOVA1
  Hsa-miR-206    SFRP1

![Consensus target genes of differentially expressed microRNAs. The target genes of the differentially expressed microRNAs were predicted with three online databases (TargetScan, miRDB, and miRTarBase).](WJG-24-5259-g004){#F4}

![CeRNA networks of long-noncoding RNA-microRNA-mRNA in colorectal cancer. The red represents the upregulated and the blue represents downregulated. Diamonds represent long-noncoding RNAs, balls represent mRNAs, and rectangles represent microRNAs.](WJG-24-5259-g005){#F5}

Functional analysis of DEmRNAs in ceRNA networks
------------------------------------------------

To better reveal the function of ceRNA networks in CRC, we subjected the 54 DEmRNAs in the ceRNA networks to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using KEGG Orthology Based Annotation System (KOBAS) 3.0, and the top ten KEGG pathways are shown in Table [3](#T3){ref-type="table"}. There were nine pathways related to cancer, including "Colorectal cancer", "p53 signaling pathway", "Chronic myeloid leukemia", "Proteoglycans in cancer", "miRNAs in cancer", "Thyroid cancer", "Transcriptional misregulation in cancer", "Pathways in cancer", and "Wnt signaling pathway". These results indicate that ceRNA networks play important roles in the carcinogenesis and progression of CRC.

###### 

Top 10 Kyoto Encyclopedia of Genes and Genomes pathways enriched by the differentially expressed mRNAs involved in competing endogenous RNAs networks

  **Pathway ID**   **Description**                                            ***P* value**   **Gene name**
  ---------------- ---------------------------------------------------------- --------------- --------------------------
  hsa05210         Colorectal cancer                                          8.18E-05        TCF7, CCND1, TGFB2
  hsa04115         p53 signaling pathway                                      1.11E-04        SERPINE1, CCND1
  hsa05220         Chronic myeloid leukemia                                   1.30E-04        CCND1, CBL, TGFB2
  hsa05205         Proteoglycans in cancer                                    1.52E-04        CCND1, CBL, TGFB2, PLAU
  hsa05206         MicroRNAs in cancer                                        6.20E-04        ZEB1, CCND1, PLAU, TGFB2
  hsa05216         Thyroid cancer                                             7.31E-04        TCF7, CCND1
  hsa04550         Signaling pathways regulating pluripotency of stem cells   8.67E-04        SOX2, KLF4, HAND1
  hsa04310         Wnt signaling pathway                                      8.84E-04        TCF7, CCND1, SFRP1
  hsa05202         Transcriptional misregulation in cancer                    1.69E-03        SP1, PLAU, ZEB1
  hsa05200         Pathways in cancer                                         1.74E-03        TCF7, CCND1, CBL, TGFB2

DEGs related with prognosis of CRC patients
-------------------------------------------

We preformed Kaplan-Meier curve analysis to identify the DEGs in the ceRNA networks that are related to overall survival. The results showed that 3 DElncRNAs (IGF2-AS, POU6F2-AS2, and LINC00488), 3 DEmiRNAs (hsa-miR-32, hsa-miR-141, and hsa-miR-375), and 2 DEmRNAs (PHLPP2 and SERPINE1) were associated with the clinical prognosis of patients. The Kaplan-Meier curves showed that the lncRNAs IGF2-AS and POU6F2-AS2, as well as hsa-miR-32, hsa-miR-141, and serpin peptidase inhibitor, clade E member 1 (SERPINE1) were negatively correlated with overall survival, whereas LINC00488, hsa-miR-375, and PH domain and leucine rich repeat protein phosphatase 2 (PHLPP2) were positively correlated with overall survival (Figure [6](#F6){ref-type="fig"}).

![Kaplan-Meier curves for the 3 long-noncoding RNAs, 3 microRNAs, and 2 mRNAs that are associated with overall survival in colorectal cancer. The differentially expressed genes were ranked by the median of expression and then scored for each colorectal cancer patient in accordance with high or low-level expression (horizontal axis: overall survival time; vertical axis: survival function).](WJG-24-5259-g006){#F6}

The ceRNA networks illustrated that PHLPP2 may be regulated by hsa-miR-32 and hsa-miR-141. Interestingly, PHLPP2 as well as hsa-miR-32 and hsa-miR-141 has been previously related to patient prognosis. We used the STRING protein database to analyze the protein-protein interactions of SERPINE1 and PHLPP2. The results revealed that SERPINE1 and PHLPP2 interact with V-akt murine thymoma viral oncogene homolog 1 (AKT1). Moreover, SERPINE1 can interact with several proteins including vascular endothelial growth factor A (VEGFA), vitronectin (VTN), transforming growth factor, beta 1 (TGFB1), plasminogen activator, urokinase (PLAU), plasminogen activator, urokinase receptor (PLAUR), plasminogen (PLG), and plasminogen activator, tissue (PLAT). Additionally, PHLPP2 can interact with AKT2 and AKT3 (Figure [7](#F7){ref-type="fig"}).

![Protein-protein interactions of PHLPP2 and SERPINE1. The STRING protein database was utilized to analyze the protein-protein interactions of SERPINE1 and PHLPP2.](WJG-24-5259-g007){#F7}

Expression of IGF2-AS, POU6F2-AS2, and LINC00488 in cell lines
--------------------------------------------------------------

To further confirm our *in silico* results, we performed RT-qPCR to detect the expression levels of IGF2-AS, POU6F2-AS2, and LINC00488 in CRC cell lines (HT29, LoVo, and SW480) and in a normal intestinal epithelial cell line (NCM460). We found that the expression of IGF2-AS and POU6F2-AS2 was significantly increased in CRC cell lines. Conversely, LINC00488 was downregulated in CRC cell lines compared with NCM460 (Figure [8](#F8){ref-type="fig"}).

![IGF2-AS, POU6F2-AS2, and LINC00488 expression levels in colorectal cancer cell lines. The expression of the three long-noncoding RNAs in HT29, LoVo, and SW480 and normal intestinal epithelial cell line NCM460 was detected by RT-qPCR and GAPDH was used as an internal control. ^a^*P* \< 0.01.](WJG-24-5259-g008){#F8}

DISCUSSION
==========

The role of ceRNAs in tumorigenesis and development has remained controversial\[[@B21]\]. However, many studies have revealed the regulatory function of ceRNA networks in proliferation, invasion, metastasis, and epithelial-mesenchymal transition (EMT). This urgently requires the establishment of a comprehensive regulatory network based on a large sample size of whole genome sequences. By constructing regulatory networks, we can better clarify the role of ceRNAs and provide direction for further research.

In this study, we integrated lncRNA, miRNA, and mRNA high-throughput data from TCGA and constructed ceRNA networks. KEGG pathway analysis of DEmRNAs indicated that ceRNA networks may regulate CRC progression *via* multiple mechanisms. It is noteworthy that "Colorectal cancer" was the most significant pathway in which transcription factor 7 (TCF7), cyclin D1 (CCND1), and transforming growth factor, beta 2 (TGFB2) are involved. TCF7 is a critical signaling molecule in the WNT/β-catenin pathway, which belongs to the TCF/LEF1 family\[[@B22]\]. The WNT/β-catenin pathway is recognized as a key regulator in cancer by transcriptionally activating a variety of oncogenes including CCND1\[[@B23]\]. CCND1 has been validated as an oncogene in CRC, and it regulates the cell cycle transition from the G1 phase to the S phase\[[@B24]\]. Chen et al\[[@B25]\] showed that TGFB2 induces CRC migration, metastasis, and the EMT by promoting SNAIL and SLUG expression.

To identify novel prognosis-related biomarkers, we applied Kaplan-Meier curve analysis to identify DEGs in ceRNA networks that correlated with clinical features among CRC patients. Ultimately, we detected 3 DEmiRNAs (hsa-miR-32, hsa-miR-141, and hsa-miR-375), and 2 DEmRNAs (PHLPP2 and SERPINE1) that may be indicators of prognosis. Wu et al\[[@B26]\] showed that hsa-miR-32 promoted CRC growth, migration, and invasion by downregulating PTEN. Feng et al\[[@B27]\] revealed that hsa-miR-141 may act as a biomarker for the early detection of recurrence during CRC surveillance. Cui et al\[[@B28]\] found that hsa-miR-375 acts as an anti-oncogene through the inhibition of SP-1, BCL-2, and other EMT-associated genes. Increased SERPINE1 expression has been found in G3/G4 CRC cells, which may be a predictor of CRC invasiveness, progression, and overall survival\[[@B29]\]. PHLPP2, a protein phosphatase, is an isoform of PHLPP. PHLPP2 negatively regulates RAF/MEK/ERK signaling by directly inhibiting RAF1 activity to inhibit the progression of cancer\[[@B30]\]. Li et al\[[@B31]\] and Liao et al\[[@B32]\] reported that hsa-miR-938 and hsa-miR-224 repressed PHLPP2 expression in CRC. In the ceRNA networks identified here, our prediction showed that PHLPP2 is targeted by hsa-miR-141, hsa-miR-32, and hsa-miR-424. We noted that the hsa-miR-141/PHLPP2 and hsa-miR-32/PHLPP2 axis in ceRNA networks may be a diagnostic biomarker and a therapeutic target for the treatment of CRC.

In the present study, 1043 DElncRNAs were detected in 644 CRC tissues compared to 51 normal tissues. Among them, 3 DElncRNAs (IGF2-AS, POU6F2-AS2, and LINC00488) were related to the prognosis of CRC. The lncRNA IGF2-AS is an antisense lncRNA for IGF2, and has been validated to promote hepatitis C virus replication\[[@B33]\]. In our work, IGF2-AS may regulate target genes by competitive sponging against hsa-miR-150 and hsa-miR-193b. The lncRNA POU6F2-AS2 has been demonstrated to be overexpressed in esophageal squamous cell cancer, which can directly target the Ybx protein and protect cancer cells from ionizing radiation\[[@B34]\]. We predicted that hsa-miR-375 interacts with POU6F2-AS2, which is related with clinical prognosis. Additionally, hsa-miR-375 is related to overall survival. The POU6F2-AS2/hsa-miR-375 axis may be another crucial diagnosis-related target. However, little is known about LINC00488. To confirm the expression levels of these three lncRNAs, we performed RT-qPCR in CRC cell lines. The results were consistent with the *in silico* analysis results. Additionally, little is known about the functions of IGF2-AS, POU6F2-AS2, and LINC00488 in CRC. Thus, additional research is needed to explore the biological and molecular mechanisms of these DElncRNAs in CRC.

In summary, we analyzed the expression profiles of CRC samples from TCGA and constructed ceRNA networks of the DEGs. KEGG pathway analysis further confirmed the role of these ceRNA networks in the development of CRC. Moreover, we identified several DEGs that were related to clinical prognosis, and the expression of IGF2-AS, POU6F2-AS2, and LINC00488 was validated using RT-qPCR in cell lines. Our study deepens our understanding of ceRNA networks and provides potential therapeutic targets and prognosis-related biomarkers for further research.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

With the development of high-throughput technology, dysregulation of non-coding genes has been revealed in colorectal cancer (CRC). Furthermore, accumulating studies have demonstrated that long-noncoding RNAs (lncRNAs) function as competing endogenous RNAs (ceRNAs) to regulate oncogene and tumor suppressor gene expression by sponging microRNAs (miRNAs). In the present research, we constructed and analyzed the ceRNA networks and found the prognosis-related differentially expressed genes (DEGs) by bioinformatics analysis.

Research motivation
-------------------

CRC is one of the most common malignancies in the world and the prognosis of patients in advanced stage remains poor. Therefore, specific biomarkers and novel therapeutic strategies are urgently required to improve the diagnosis and prognosis for CRC patients.

Research objectives
-------------------

In our research, we aimed to construct ceRNA networks that include differentially expressed (DE)mRNAs, DElncRNAs, and DEmiRNAs based on co-expression database. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and protein-protein interactions network analysis were performed to confirm the importance of ceRNA networks in the development of CRC. Importantly, our study provides new potential lncRNA/miRNA/mRNA axis for future research and clinical practice.

Research methods
----------------

We obtained CRC tissue and normal tissue gene expression profiles from The Cancer Genome Atlas project. DEGs were identified by using the edgeR package in R software. Then, upregulated and downregulated miRNA-centered ceRNA networks were constructed by analyzing the DEGs using multiple bioinformatics approaches. The networks were visualized and mapped using Cytoscape software. DEmRNAs in the ceRNA networks were identified in KEGG pathways using KEGG Orthology Based Annotation System 3.0. Kaplan-Meier survival analysis was conducted for DEGs and real time quantitative polymerase chain reaction (RT-qPCR) was performed to verify the prognosis-associated DElncRNAs in CRC cell lines.

Research results
----------------

We constructed CRC ceRNA networks which included 81 DElncRNAs, 20 DEmiRNAs, and 54 DEmRNAs. KEGG pathway analysis indicated that nine pathways were related to cancer and the most significant pathway was "Colorectal cancer". According to Kaplan-Meier curve analysis, the overall survival was positively associated with five DEGs (IGF2-AS, POU6F2-AS2, hsa-miR-32, hsa-miR-141, and SERPINE1) and it was negatively related to three DEGs (LINC00488, hsa-miR-375, and PHLPP2). The expression of prognosis-related DElncRNAs in CRC cell lines was consistent with the *in silico* results.

Research conclusions
--------------------

In the present study, we provide a new pathway to construct ceRNA networks for cancer research and novel insights on non-coding RNAs in CRC. We identified and constructed the ceRNA networks of CRC in large cohorts. Enrichment analysis results verified the critical role of the ceRNA networks in CRC. Besides, multiple prognosis-related DEGs found in this research could be used as potential biomarkers and therapeutic targets.

Research perspectives
---------------------

Further exploration of ceRNA networks provided a number of potential biomarkers and therapeutic targets for CRC. However, much more work is needed to reveal the function and mechanism of prognosis-related DEGs in the future.
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